Elopak reported its first quarter with revenue above EUR300m, translating to EBITDA of EUR45m, 3% above our estimate and 1% above consensus. Despite a strong top line, margins contracted 2.6%-points QOQ due to pre-production costs related to its new facility in Little Rock and continued imports from JVs and Europe. We have adjusted our 2026–2027e EPS by 2–1% and reiterate our HOLD, but have increased our target price to NOK44 (40), mainly due to lower tariff concerns and multiples expansion amon...
We estimate Q1 EBITDA of EUR44m, down 6% YOY and 2% below consensus. With EMEA still seeing weak consumer sentiment, we expect a 3% decline in divisional revenue, partly offset by pent-up machine sales. Q1 is set to be the last quarter without commercial support from Little Rock; we expect a flat trend QOQ on continued production constraints. We have lowered our 2026–2027e EPS by 2–1%. We reiterate our HOLD, but have cut our target price to NOK40 (44).
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.